Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281229 · ClinicalTrials.gov registry record
T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 481
- Enrollment target
NCT00281229 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 481 participants.
The verdict
NCT00281229 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 481 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the lungs of individuals with chronic obstructive pulmonary disease (COPD) contain resident memory T lymphocytes that can produce a combination of cytokines that induce the symptoms of an acute exacerbation of COPD (AE-COPD). Specifically, the study will determine cell-surface receptors of lung T cells in comparison with blood T cells from the same subject, and will examine anti-CD3-activated blood or lung T cells for interleukin (IL)-6 and interferon-gamma production in response to IL-18, and for IL-17A production in response to recombinant IL-23.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 481 participants |
| Start Date | 2005-09 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00281229
The ClinicalTrials.gov registry entry for NCT00281229 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 481 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00281229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00281229 about?
NCT00281229 is a clinical study titled "T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease". The purpose of this study is to determine whether the lungs of individuals with chronic obstructive pulmonary disease (COPD) contain resident memory T lymphocytes that can produce a combination of cytokines that induce the symptoms of an acute exacerbation of COPD (AE-COPD). Specifically, the study ...
What is the current status of trial NCT00281229?
This trial is currently completed. The enrollment target is 481 participants. The study started on 2005-09. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT00281229?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.